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Summary: A relatively simple, very sensitive bioluminescence-enhanced detection System for protein blots is
described. The method utilizes antibodies conjugated with alkaline phbsphatase. The alkaline phosphatase
then takes part in a reaction by releasing ZMuciferin (Photinus pyralis) from D-luciferin-O-phosphate.
Liberated ZMuciferin reacts with luciferase, ATP and oxygen with light emission. The light is detected by a
sensitive photographic film, thereby permitting the visualization of the alkaline phosphatase-conjugated
antibodies. Under non-optimized conditions the limit of detection is at present 5 to 50 pg of protein,
corresponding e.g. to 30 to 300 "18 mol of rabbit immunoglobulin G. The detection System is therefore
100 times more sensitive than other Systems used at present.
Introduction
Protein blot analyses are now extensively used for
research and for diagnosis of infectious diseases, e. g.
hepatitis or acquired immuüödeficiency syndrome
(AIDS) (1-6). The first practical methods for trans-
fer of proteins frorn gel electropherograms to cellu^
lose or nitrocellulose were published in 1979 (7—9)
and since that time there has been an explosive in-
creäse in äpplicatioris öf these techniques (for a review
see 1. c. (10)). In the beginning, radioactive labels were
used to inerease the sensitivity of antigen detection
(7, 8, 11, 12). During recent years noii-radioactive
labels such äs horseradish peroxida^e1) or alkaline
phosphatase1) have been introduced (13—21), which
allow a compafable sensitivity öf detection. As little
äs l to 10 ng of protein can be detected under optimal
conditions.
*) Enzymes:
Alkaline phosphatase (EC 3.1.3.1);
human tissue (urinary) kallikrein (EC 3.4.21.35);
porcine polymorphonuclear leukocyte elastase
3.4.21.37, fprmerly EC 3.4.21.11);
horse radish peroxidase (EC 1.11.1.7);
luciferase (EC 1.13.12.7).
(EC
In this conununication we describe the development
of a bioluminescence-enhanced detection System with
a greatly increased sensitivity of detection for protein
blotting.
Materials and Methods
Synthetic D-luciferin (Photinus pyralis), ATP, alkaline phospha-
tase (calf intestine; 200—400 U/mg; 25 °C) and rabbit immuno-
globulin G were purchased from Sigma, Taufkirchen, FRG.
Human urinary kallikrein1) and porcine leukocyte elastase1)
were isolated äs described by Geiger et al. (22, 23). Luciferase1)
(Photinus pyralis; spec. act. 8mU/mg) was a product of
Boehringer, Mannheim, FRG.
Z)-luciferin-O-phosphate was synthesized äs described in I.e.
(24). The Substrate is commercially available from Novabio-
chem AG, CH-4448 Läufelfingen, Switzerland.
Antibodies against human urinary kallikrein, porcine leukocyte
elastase and rabbit immunoglobulin G were raised in rabbits
and goats äs described in 1. c. (25). Anti-rabbit IgG goat immu-
noglobulin alkaline phosphatase conjugate was synthesized äs
described by Geiger et al. (26).
Nitrozellulose filters (BA 85, 0.45 ) were products of Schlei-
cher and Schüll, Dassel.
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Photographic film, Tri X pan, 380 ASA, was purchased from
Kodak AG, Stuttgart, and developed using a procedure given
by the manufacturers.
Protein transfer or protein blotting was performed äs described
in 1. c. (27) and (28).
Bioluminescent deteetion of immunoblotted pro-
teins
Protein was transferred to nitrocelhilose soaked with phosphate
buffer (6.5 mmol/1 Na2HPO4, 1.5 mmol/1 KH2PO4, 137 mmol/1
NaCl, 2.7 ramol/1 KC1, pH 8.0) äs described in 1. c. (27) and
(28). Nitrocellulose was then blocked with 50 g/l bovine serura
albumin in phosphate bufter for 2 h at 25 °C. Then the filter
was incubated for 2 h at 25 °C in phosphate buffer containing
anti-rabbit IgG alkaline phosphatase conjugate (l: 500 dilution
of conjugate in phosphate buffer). Thereafter the filter was
washed 3 times with phosphate buffer without conjugate and
transfered to a transparent plastic dish containing about 6 ml
of the deteetion solution (40 mmol/1 HEPES buffer, 1.6 mmol/1
diethanolamine, 6 mmol/1 MgCl2, 0.54 mmol/1 EDTA, 3.4
mmol/1 dithiothreitol 2.6 mmol/1 ATP, 2 mmol/1 luciferin-O-
phosphate, 0.15 mg luciferase, pH 8.0). The dish was placed
on a photographic film in the dark for 2 h. After development
(5 min at 25 °C in a solution of Kodak HC-110) and fixation
of the film, the position of protein binding antibody was re-
vealed äs dark spots.
Results and Discussion
We report here an alternative, sensitive, biolumines-
cence-enhanced deteetion method of protein blotting.
The principle of bioluminescent protein blotting is
shown in figure 1. After application of proteins to a
nitrocellulose filter, either by direct application or by
electric transfer, an antibody alkaline phosphatase
conjugate is added. Protein-boünd alkaline phospha-
tase conjugate liberates luciferin frorn the Substrate
luciferin-O-phosphatej arid luciferin is oxidized by
luciferase (Photinus pyralis) under light emission (fig.
2). Emitted light exposes a sensitive photographic
film. Thus specifically bound alkaline phosphatase
conjugate can be visualized after development.
In the deteetion step, alkaline phosphatase and luci-
ferase (Photinus pyralis) must both be active in the
same buffer solution. The pH optima of these en-
zymes, pH 7.75 for luciferase (Photinus pyralis) and
pH 9.6 for alkaline phosphatase are different. 'Based
on the results depicted in figure 3, a buffer of pH 8.0
was chosen, where alkaline phosphatase and lucifer-
ase are still suffieiently active.
Since commercial deteetion equipment is not avail-
able, we used a home-made device, äs shown in
figure 4.
Figure 5 shows an example of a photographic film,
where even spots corresponding to 5 pg protein (rab^
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Fig. l. Scheine of the biolummescence-eiihänced deteetion System of protein blotting. >-(AP) = antibody alkaline phosphatase
conjugate.
Alk. Phosphatase
1) /)-Luciferin-O-phosphate > Z>-Luciferin 4· Pj
Luciferase
2)/)-Luciferin -h O2 + ATP > Oxyluciferin + h · v + AMP + PPj
(Mg2+)
Fig. 2. Scheine of bioluminescence reaction using firefly luciferase (Photinus pyralis).
» »
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The detection System has been successfully used for
the following antigens: rabbit immun globulin G,
human urinary kallikrein and porcine leukocyte elas-
tase. The detection System is at present not optimized
with respect to sensitivity of photographic film and
exposure time, but enzyme activities are stable for
two hours using the detection buffer described above.
Limits of detection determined for the present
method are between 5 and 5000 pg (corresponding










Fig. 3. pH optima of calf intestine alkaline phosphatase (Δ)
and firefly (Photinus pyralis) luciferase (o).
For details, see I.e. (24).
to 1Ό"16 inol of human urinary kallikrein and to
7 χ 10"16 mol of porcine leukocyte elastase) at an
exposure time of 2 hours. Taking into account that
the measurement of light is performed under non-
optimal conditions (only exposure of photographic
film, no use of electronical photomultipliers or Scan-
ners) the detection limits can be lowered by powers
of ten even at a shorter exposure time of the film. By
the use of sensitive electronical detection Systems,
e. g. a photomultiplier or a luminometric Scanner,
protein samples could be measured by the same prin-
ciple in the femtogram r nge (< 10~18 mol), s dem-
onstrated recently for bioluminescence-enhanced im-
munoassays (24, 26).
Very sensitive detection Systems are nowdays of
special interest. By their use many problems in science
and diagnosis could be solved more rapidly and at
an earlier stage, such s the quick determination of
low concentrations of proteins or peptides produced
by recombinant techniques in microorganisms or cul-
ture broth (29) or the determination of low antibody
titers in the first stages of antibody formation, e. g.
in diseases like acquired immunodeficiency syndrome
(AIDS).
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i Photographicfilm Dark box
Fig. 4. Scheine of the device used for the vis alization of the biolumineseence-enhanced detection System.
Fig. 5. Photographic detection of a protein blot on niiroccllu-
lose filter.
For detail see Methods.
a, 50 ng; b, 5 ng; c, 500 pg; d, 50 pg; e, 5 pg rabbit
immun globulin G.
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